All drug concentrations were simultaneously combined in a non-constant ratio or constant ratio, and the combination index (CI) values were calculated by the Chou-Talalay method with CompuSyn software [19,20]. In general, combinations with a CI value < 1.0 are considered synergistic, and the closer the index is to 0, the stronger the synergism [20]. The non-constant ratio experiments were carried out with a fixed concentration of CDK4/6is (palbociclib and abemaciclib, 0.5–1 µM) and variable concentrations of PARPis (olaparib and rucaparib, 0.5–10 µM). The constant ratio (1:5) combination experiments were carried out by serial dilution (1:2) of the mixture of palbociclib (2 µM) and olaparib (10 µM).
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.